Effects of DQ-113, a New Quinolone, against Methicillin- and Vancomycin-Resistant Staphylococcus aureus-Caused Hematogenous Pulmonary Infections in Mice

We compared the effects of DQ-113, a new quinolone, to those of vancomycin (VCM) and teicoplanin (TEIC) in murine models of hematogenous pulmonary infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and VCM-insensitive S. aureus (VISA). The MICs of DQ-113, VCM, and TEIC for MRSA...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Kaneko, Yukihiro, Yanagihara, Katsunori, Miyazaki, Yoshitsugu, Tsukamoto, Kazuhiro, Hirakata, Yoichi, Tomono, Kazunori, Kadota, Jun-ichi, Tashiro, Takayoshi, Murata, Ikuo, Kohno, Shigeru
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 2003
Предмети:	Experimental Therapeutics
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296226/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14638467/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.12.3694-3698.2003
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!